$CLNE Cashflow Statement | Understand Stock

$CLNE

$1.45 -$0.01 (0.68%) Close

$CLNE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization
Provision for credit losses and inventory
Stock-based compensation expense
Stock-based sales incentive charges
Change in fair value of derivative instruments
Amortization of discount and debt issuance cost
(Gain)/Loss on sale of BTR equity and convertible promissory note
Amortization of debt financing costs
Amortization of discounts and Section 30C tax credit
Loss on disposal of property and equipment
Loss on extinguishment of debt
Gain from sale of certain assets of subsidiary
Gain from formation of equity method investment
Extinguishment of unamortized discount on expiration of deferred drawdown
Asset impairments and other charges
Impairment of goodwill
Impairment of investments in equity securities
Loss from equity method investments
Non-cash lease expense
Deferred income taxes
Expense reimbursement from JV
Accretion of ARO liabilities
Changes in operating assets and liabilities:
Accounts and other receivables
Inventory
Prepaid expenses and other assets
Operating lease liabilities
Accounts payable
Deferred revenue
Accrued liabilities and other

Net cash provided by operating activities
Cash flows from investing activities:
Purchases of short-term investments
Maturities and sales of short-term investments
Payment and deposits on equipment and manure rights for ADG RNG production projects
Purchases of and deposits on property and equipment
Grant proceeds for capital projects
Proceeds received for joint development and construction of station projects
Disbursements for loans receivable
Proceeds from paydowns, maturities, and sales of loans receivable
Cash received from sale of certain assets of subsidiary, net
Investments in other entities
Advance to DR JV
Proceeds from repayment of advance by DR JV
Proceeds from settlement of insurance claims
Proceeds from disposal of property and equipment
Net cash provided by (used in) provided by investing activities
Cash flows from financing activities:
Issuance of common stock
Repurchase of common stock
Payment of tax withholdings on net settlement of equity awards
Fees paid for issuance of common stock
Fees paid for lender and debt issuance costs
Proceeds for Adopt-A-Port program
Repayment of proceeds for Adopt-A-Port program
Proceeds from debt instruments
Proceeds from revolving line of credit
Repayments of borrowing under revolving line of credit
Repayments of debt instruments and finance lease obligations
Repayment of Stonepeak Debt
Payments of debt extinguishment costs
Net cash provided by (used in) financing activities
Effect of exchange rates on cash, cash equivalents and restricted cash
Net increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of period
Cash, cash equivalents and restricted cash, end of period
Supplemental disclosure of cash flow information:
Income taxes paid
Interest paid, net of $2,587 and $2,057, $7,120 capitalized, respectively
Supplemental disclosure of non-cash financing activity:
Interest paid-in-kind

Comments